[Federal Register Volume 63, Number 106 (Wednesday, June 3, 1998)]
[Notices]
[Pages 30231-30233]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-14658]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 98063]
Notice of Availability of Funds; Cooperative Agreement for
National Hepatitis B Immunization Program with Focus on Asians and
Pacific Islanders
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year FY 1998 funds for a cooperative agreement
to support a Hepatitis B Immunization Project with a focus on Asians
and Pacific Islanders. The purpose of this cooperative agreement
program is to increase hepatitis B vaccination levels among Asian and
Pacific Islander (API) children in the United States born between 1983
and 1993 from a baseline of 10 percent in 1996 to 90 percent by the
close of year 2000, to enhance local demand for hepatitis B vaccination
of API children, and to inform and educate vaccination service
providers who serve API children. This program addresses the ``Healthy
People 2000'' priority area of Immunization, and Infectious Diseases.
B. Eligible Applicants
Applications may be submitted by public and private nonprofit (and
for-profit) organizations, and by governments and their agencies; that
is, universities, colleges, research institutions, hospitals, other
public and private non profit organizations, State and local
governments or their bona fide agents, and federally recognized Indian
tribal governments, Indian tribes, or Indian tribal organizations.
Note: Public Law 104-65 states that an organization described in
section 501(c)(4) of the Internal Revenue Code of 1986 that engages
in lobbying activities is not eligible to receive Federal funds
constituting an award, grant, cooperative agreement, contract, loan,
or any other form.
C. Availability of Funds
Approximately $49,900 is available in FY 1998 to fund one award. It
is expected that the award will begin on or about July 31, 1998, and
will be made for a 12-month budget period within a project period of up
to three years. Funding estimates may change.
[[Page 30232]]
Continuation awards within an approved project period will be made
on the basis of satisfactory progress as evidenced by required reports
and the availability of funds.
D. Program Requirements
In achieving the purpose of this effort, the recipient will be
responsible for the activities listed under Item 1, (Recipient
Activities) and CDC will be responsible for the activities listed under
Item 2, (CDC Activities).
1. Recipient Activities
The recipient will promote hepatitis B immunization of all API
children in the United States through collaborative education and
vaccination activities and sharing of information and resources through
the member groups, working groups, volunteers, and national, State, and
local public and private health care providers. The grantee will:
a. Recipient should conduct meetings, form working groups, and
maintain reports and other records as necessary related to Hepatitis B
Immunization activities.
b. Work with targeted national organizations and State and local
coalitions to facilitate API hepatitis B vaccination coverage surveys
and implementation of efforts to educate providers and parents about
hepatitis B vaccine (HBV), Vaccines for Children (VFC) Program, and the
national recommendations to vaccinate all API children with hepatitis B
vaccine.
c. Work with State and local coalitions to identify barriers and
solutions to these barriers in the implementation of hepatitis B
vaccination of all API children.
d. Regularly inform all work groups and volunteers and relevant
national, State and local groups of recipient related activities around
the country with a published vehicle such as a newsletter.
e. Develop strategies, action plans, and mechanisms to increase
public and private collaboration on activities to ensure hepatitis B
vaccination of all API children in the U.S., for example, such as
establishing a Web page; organizing volunteer groups; organizing fund-
raising efforts; developing and utilizing mailing lists; working with
Asian language school principals; meeting with Asian language media
spokespersons; and working through the federal Vaccines for Children
(VFC) network to enroll and educate providers of vaccination services
to API children in each of the 12 top API states--California, New York,
Hawaii, Texas, Illinois, New Jersey, Washington, Florida, Virginia,
Maryland, Pennsylvania, and Massachusetts.
f. Establish working relationships with API health care providers
to enhance their interest and participation in the project.
g. Devise and implement a linkage of a majority of the existing
hepatitis B virus transmission prevention resources with a majority of
the nation's API community leaders.
2. Centers for Disease Control and Prevention (CDC) Activities
a. As requested, provide assistance to the recipient, with plans or
agendas for proposed activities.
b. Provide technical assistance through telephone calls,
correspondence, and site visits in the area of program and agenda
development, implementation, and priority setting related to the
cooperative agreement.
c. Provide scientific collaboration for appropriate aspects of the
activities, including information on disease impact and vaccination
coverage levels.
d. Provide speakers, when possible, on such topics and impact of
HBV infection in API's, national policy and recommendations related to
hepatitis B vaccination of API children.
e. Assist as requested in reporting and validating relevant
hepatitis B vaccination information made available through publication
in a newsletter and journal articles and otherwise provided to project
members, volunteers, Federal, State, and local health agencies, and
health care providers.
f. Provide representatives to attend executive, steering group and
work group conference calls and meetings.
E. Application Content
The application must contain the following:
1. Objectives consistent with the existing purpose of the applicant
organization.
2. Background information on the applicant; evidence of relevant
experience in coordinating groups of diverse organizations; evidence of
the applicant's organizational capacity and experience in building and
maintaining relationships with national organizations, private and
public sector non-profit health care organization, professional health
associations, volunteer groups, advocacy groups, API organizations, and
government entities.
4. A clear description of the purpose of the applicant organization
along with detailed methods and activities which will be undertaken to
ensure vaccination of at least 90 percent of all API children in the
U.S. with hepatitis B vaccine by the close of year 2000.
5. A plan to monitor and evaluate activities.
6. Biographical information on qualified and experienced
administrative and professional personnel who will be working in an
existing organizational structure to fulfill the terms of the project.
7. Letters from current API organizations, API community leaders,
and State and local public health agencies which indicate the applicant
has their support and involvement in conducting the activities of this
project and has an established reputation to motivate other
organizations.
8. A detailed budget and narrative budget justification.
Competing Applications
Use the information in the Program Requirements, Other
Requirements, and Evaluation Criteria sections to develop the
application content. Your application will be evaluated on the criteria
listed, so it is important to follow them in laying out your program
plan. The narrative should be no more than 30 double-spaced pages,
printed on one side, with one inch margins, and unreduced font.
F. Submission and Deadline
Application
Submit the original and two copies of PHS 5161-1 (OMB Number 0937-
0189) on or before July 6, 1998. Submit the application to: David
Elswick, Grants Management Specialist, Grants Management Branch,
Procurement and Grants Office, Announcement 98063, Centers for Disease
Control and Prevention (CDC), Room 300, 255 East Paces Ferry Road, NE.,
Mailstop E-13, Atlanta, Georgia 30305-2209.
If your application does not arrive in time for submission to the
independent review group, it will not be considered in the current
competition unless you can provide proof that you mailed it on or
before the deadline (i.e., receipt from U.S. Postal Service or a
commercial carrier; private metered postmarks are not acceptable).
G. Evaluation Criteria
Each application will be evaluated by an independent review group
appointed by CDC to the extent it documents the applicant's:
1. understanding of the existing disease control problem and the
importance and feasibility of hepatitis B vaccination of at least 90
percent of all API children in the U.S. by the close of year 2000. (10
percent)
[[Page 30233]]
2. specific, realistic, measurable, and time-phased objectives
which are related to effective activities. (15 percent)
3. high quality and effective plan for ensuring implementation of
State and local successful hepatitis B vaccination efforts in at least
the top 12 API states. (20 percent)
4. established network of national, State or local collaborators
and accessibility to an adequate number of member organization
representatives. (20 percent)
5. administrative and support staff to operate the project. (10
percent)
6. qualified and experienced professional personnel who are
committed to the project and will implement the proposed program
activities. (10 percent)
7. appropriate and effective plan to measure activities and
evaluate its progress toward the year 2000 goal. (15 percent)
In addition, consideration will be given to the extent to which the
budget request is clearly justified and consistent with the intended
use of cooperative agreement funds.
H. Other Requirements
Technical Reporting Requirements
A. Provide CDC with original plus two copies of:
1. quarterly progress reports describing the progress toward
achieving objectives, implementing vaccination programs, and providing
services;
2. financial status report, no more than 90 days after the end of
the budget period; and
3. final financial and performance reports, no more than 90 days
after the end of the project period.
B. Provide an annual report to the project members, summarizing
activities and accomplishments of the project.
Send all reports to: David Elswick, Grants Management Specialist,
Grants Management Branch, Procurement and Grants Office, Centers for
Disease Control and Prevention (CDC), Room 300, 255 East Paces Ferry
Road, NE., Mailstop E-13, Atlanta, GA 30305-2209.
The grantee will visit CDC, NIP at least twice a year for a verbal
progress report on all project activities.
The following additional requirements are applicable to this
program.
AR98-11 Healthy People 2000
AR98-12 Lobbying Restrictions
AR98-7 Executive Order 12372 Review
AR98-8 Public Health System Reporting Requirements
I. Authority and Catalog of Federal Domestic Assistance Number
This program is authorized under the Public Health Service Act,
Section 317(k)(1)[42 U.S.C. 247b(k)(1)], as amended. The Catalog of
Federal Domestic Assistance number is 93.185.
J. Where to Obtain Additional Information
Please refer to Program Announcement 98063 when you request
information. For a complete program description, information on
application procedures, an application package, and business management
assistance, contact: David Elswick, Grants Management Specialist,
Grants Management Branch, Procurement and Grants Office, Announcement
98063, Centers for Disease Control and Prevention (CDC), Room 300, 255
East Paces Ferry Road, NE., Mailstop E-13, Atlanta, GA 30305-2209,
telephone (404) 842-6521, Email address DCE[email protected].
See also the CDC home page on the Internet: http://www.cdc.gov
For program technical assistance, contact Gary L. Euler, DrPH,
Chief, Hepatitis Activity, Adult Vaccine Preventable Diseases Branch,
Epidemiology and Surveillance Division, National Immunization Program,
Centers for Disease Control and Prevention (CDC), 1600 Clifton Road,
NE., Mailstop E-61, Atlanta, GA 30333, telephone (404) 639-8742,
Internet address: [email protected].
To receive additional written information and to request an
application kit, call 1-888-GRANTS4 (1-888 472-6874). You will be asked
to leave your name and address and will be instructed to identify the
Announcement number of interest.
Dated: May 28, 1998.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention.
[FR Doc. 98-14658 Filed 6-2-98; 8:45 am]
BILLING CODE 4163-18-P